This finding is highly significant in the context of modern T2DM treatment, where DPP4 inhibitors like sitagliptin are established first-line therapies that work by prolonging the activity of incretin hormones 3 , 4 , 21 .
← all excerpts
Probing the mechanisms of flavonoids in corn silk for treating type 2 diabetes by in Silico and in vitro experiments.
1
—
—